News June 19, 2022 MDUFA V – progress! WASHINGTON, D.C. – The Senate Health, Education, Labor and Pensions Committee today passed S.… Super User 0 Love0
News June 19, 2022 Supply chain vulnerabilities exist for antimicrobial medicines: USP Medicine Supply Map analysis | Quality Matters | U.S. Pharmacopeia Blog Antimicrobial resistance (AMR) is named one of the top 10 global health threats facing humanity… Super User 0 Love0
News June 19, 2022 (1776) Dr. Michelle McMurry-Heath, BIO 2022 Tuesday Keynote: BIO Unbound, Clip 3 – YouTube Dr. Michelle McMurry-Heath, BIO 2022 Tuesday Keynote: BIO Unbound, June 14, 2022 SHOW LESS … Super User 0 Love0
News June 19, 2022 Synexa Life Sciences Set to Open New Bioanalytics Lab in Rockville, Maryland · BioBuzz Synexa Life Sciences (Synexa), a global leader in clinical biomarker and bioanalytics research services, recently… Super User 0 Love0
News June 19, 2022 The Power Players of Washington, D.C., 2022 – Commercial Observer (Pete Briskman Listed) What a roller coaster. After stomach-clenching drops in 2020, the Washington, D.C., area market clambered… Super User 0 Love0
News June 19, 2022 The Licensing of Academic Patents Contributed Up to $1.9 Trillion to the US Economy, Supported up to 6.5 Million Jobs in the last 25 Years | AUTM SAN DIEGO — (June 14, 2022) — The licensing of university and nonprofit research has… Super User 0 Love0
News June 19, 2022 Emergent BioSolutions inks deal for smallpox newcomer Tembexa Emergent BioSolutions, already flush with products against public health threats like anthrax attacks and opioid… Super User 0 Love0
News June 19, 2022 SNUBH opens K-BioHealth regional center < Bio < 기사본문 - KBR The Seoul National University Bundang Hospital (SNUBH) set up a "K-Bio Health Regional Center" in… Super User 0 Love0
News June 19, 2022 Children’s National Hospital is #5 in the Nation – Washingtonian Children’s National Hospital in Washington, D.C., was ranked #5 nationally in the U.S. News &… Super User 0 Love0
News June 19, 2022 Fewer Financings, Plunging Valuations May Stoke M&A Activity, EY Predicts The biopharma bear market has ended the financing boom of recent years and led the… Super User 0 Love0